Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
Open Access
Abstract
NAFLD is emerging as one of the commonest causes of abnormal liver function tests, and in the Western world the estimated prevalence is reported to be as high as 30%.1 The prevalence of NAFLD is expected to rise in developed countries given the epidemic of its major underlying determinant obesity, in addition to the increasing ascertainment of this condition. Histologically, NAFLD is a spectrum of disease from simple fatty deposition (steatosis), to necroinflammation in zone 3 in association with ballooning degeneration (non-alcoholic steatohepatitis (NASH)), to periportal and/or perisinusoidal fibrosis, to cirrhosis. The natural history is varied; at the early stages of disease the majority remain stable at the same histological stage and grade, a proportion however will progress to cirrhosis (there is variation in the rate of progression), and finally some will have regression of disease.Keywords
This publication has 54 references indexed in Scilit:
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model†Hepatology, 2005
- Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver diseaseLiver International, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesJournal of Hepatology, 2005
- Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver diseaseJournal of Hepatology, 2004
- Silent non-alcoholic fatty liver disease—a clinical–histological studyJournal of Hepatology, 2004
- Should a liver biopsy be done in patients with subclinical chronically elevated transaminases?European Journal of Gastroenterology & Hepatology, 2004
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Assessment of liver biopsies in chronic hepatitis: how is it best done?Journal of Hepatology, 2003